Cargando…

Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Kara, Emre, Demirkan, Kutay, Unal, Serhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390798/ https://www.ncbi.nlm.nih.gov/pubmed/32738307 http://dx.doi.org/10.1016/j.ijantimicag.2020.106123

Ejemplares similares

Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience
por: KARA, Emre, et al.
Publicado: (2019)

May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
por: Kara, Emre, et al.
Publicado: (2020)

Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster?
por: Bayraktar-Ekincioglu, Aygin, et al.
Publicado: (2021)

Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?
por: Yalçın, Nadir, et al.
Publicado: (2021)

Benefit versus toxicity risk of digoxin in patients with COVID-19
por: Kelleci Cakir, Burcu, et al.
Publicado: (2022)

COVID-19 & antiepileptic drugs: Should we pay attention?
por: Fırat, Oguzhan, et al.
Publicado: (2020)

Knowledge, attitudes, and practices regarding vaccination among community pharmacists
por: Ozdemir, Nesligul, et al.
Publicado: (2022)

Factors associated with intention of clinical pharmacists and candidates to provide pharmaceutical care: application of theory planned behaviour
por: Tecen-Yucel, Kamer, et al.
Publicado: (2023)

Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
por: Liu, Wang-Da, et al.
Publicado: (2021)

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
por: Thémans, Pauline, et al.
Publicado: (2020)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
por: Belayneh, Anteneh
Publicado: (2020)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
por: Fassihi, Safa C., et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Risk of using hydroxychloroquine as a treatment of COVID-19
por: Alanagreh, Lo’ai, et al.
Publicado: (2020)

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Publicado: (2020)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
por: Sun, Xiaoxuan, et al.
Publicado: (2020)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19
por: Perlis, Roy H., et al.
Publicado: (2023)

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19
por: Zhanel, George G., et al.
Publicado: (2021)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
por: Brufsky, Adam
Publicado: (2020)

Hydroxychloroquine in the prevention of COVID-19 mortality
por: Jorge, April
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0s405ihjclout4ohf834rgv1t6